We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MetLife (MET) Dips 5% Year to Date: Will it Recover in 2021?
Read MoreHide Full Article
Shares of MetLife, Inc. (MET - Free Report) have exhibited a downtrend so far this year due to the challenging economic and operating environment triggered by the COVID-19 pandemic.
Notably, in the first nine months of 2020, the company’s revenues declined 7.7% year over year due to a decline in premiums across all its major geographic segments, namely United States, Asia, Latin America and EMEA. Also, a low interest rate environment caused a decline in the net investment income, which is another revenue driver.
The company expects a hostile face-to-face global sales landscape and muted sales across most segments. This, in turn, may put pressure on the top line.
Also, the low interest rate environment (which is expected to continue through 2023) might exert pressure on net investment income because of soft investment yields.
However, strategic measures taken by the company to focus on high-growth areas and discard non-core businesses will streamline its business and restore investors’ confidence in the stock. To this end, the company recently announced that it will sell its unit, Metropolitan Property and Casualty Insurance Company and certain wholly owned subsidiaries to Farmers Group, Inc. (FGI), a subsidiary of Zurich Insurance Group.
The deal valued at $3.94 billion is likely to close in the second quarter of 2021. Also, in October 2020, the company sold its wholly-owned subsidiary MetLife Seguros de Retiro S.A. Earlier in June 2020, it divested its two wholly-owned subsidiaries MetLife Limited and Metropolitan Life Insurance Company of Hong Kong Limited (collectively, MetLife Hong Kong).
During the third quarter of 2020, the company booked the sale of its annuity business in Argentina, which was no longer the right fit for MetLife. With no material impact on the company, this divestiture helps illustrate its ongoing process of planting and pruning in a bid to achieve the optimal business mix.
Apart from selling its non-profitable businesses, the company is buying operations that come with a strategic value. Recently, it bought the vision care company Versant Health for $1.675 billion. With this buyout, MetLife made inroads into the vision insurance market and expanded its bouquet of Group Insurance offerings.
In January this year, MetLife acquired PetFirst, which enabled it to foray into the growing pet insurance market.
The company also resumed its share buyback programs, which will provide a cushion to its bottom line.
We believe, these strategic initiatives coupled with the company’s operational excellence will help the stock regain its lost momentum in the coming quarters.
MetLife’s shares have lost 4.5% year to date compared with the industry’s decline of 8.5%.
Other stocks in the same space including Prudential Financial, Inc. (PRU - Free Report) , American International Group, Inc. (AIG - Free Report) and American Financial Group, Inc. (AFG - Free Report) have lost 12.9%, 22.3% and 18.6%, respectively, over the same time period.
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Image: Bigstock
MetLife (MET) Dips 5% Year to Date: Will it Recover in 2021?
Shares of MetLife, Inc. (MET - Free Report) have exhibited a downtrend so far this year due to the challenging economic and operating environment triggered by the COVID-19 pandemic.
Notably, in the first nine months of 2020, the company’s revenues declined 7.7% year over year due to a decline in premiums across all its major geographic segments, namely United States, Asia, Latin America and EMEA. Also, a low interest rate environment caused a decline in the net investment income, which is another revenue driver.
The company expects a hostile face-to-face global sales landscape and muted sales across most segments. This, in turn, may put pressure on the top line.
Also, the low interest rate environment (which is expected to continue through 2023) might exert pressure on net investment income because of soft investment yields.
However, strategic measures taken by the company to focus on high-growth areas and discard non-core businesses will streamline its business and restore investors’ confidence in the stock. To this end, the company recently announced that it will sell its unit, Metropolitan Property and Casualty Insurance Company and certain wholly owned subsidiaries to Farmers Group, Inc. (FGI), a subsidiary of Zurich Insurance Group.
The deal valued at $3.94 billion is likely to close in the second quarter of 2021. Also, in October 2020, the company sold its wholly-owned subsidiary MetLife Seguros de Retiro S.A. Earlier in June 2020, it divested its two wholly-owned subsidiaries MetLife Limited and Metropolitan Life Insurance Company of Hong Kong Limited (collectively, MetLife Hong Kong).
During the third quarter of 2020, the company booked the sale of its annuity business in Argentina, which was no longer the right fit for MetLife. With no material impact on the company, this divestiture helps illustrate its ongoing process of planting and pruning in a bid to achieve the optimal business mix.
Apart from selling its non-profitable businesses, the company is buying operations that come with a strategic value. Recently, it bought the vision care company Versant Health for $1.675 billion. With this buyout, MetLife made inroads into the vision insurance market and expanded its bouquet of Group Insurance offerings.
In January this year, MetLife acquired PetFirst, which enabled it to foray into the growing pet insurance market.
The company also resumed its share buyback programs, which will provide a cushion to its bottom line.
We believe, these strategic initiatives coupled with the company’s operational excellence will help the stock regain its lost momentum in the coming quarters.
MetLife’s shares have lost 4.5% year to date compared with the industry’s decline of 8.5%.
Other stocks in the same space including Prudential Financial, Inc. (PRU - Free Report) , American International Group, Inc. (AIG - Free Report) and American Financial Group, Inc. (AFG - Free Report) have lost 12.9%, 22.3% and 18.6%, respectively, over the same time period.
MetLife carries a Zacks Rank #3 (Hold), currently. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>